Status:
COMPLETED
A Prospective Clinical Trial Designed to Evaluate the Repeatability and Reproducibility of the Intelon BOSS(tm) System
Lead Sponsor:
Intelon Optics, Inc
Conditions:
Corneal Transplant
Corneal Crosslinking
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This is a prospective, open-label, single-site clinical trial designed to evaluate the repeatability and reproducibility of biomechanical imaging by the updated version of the BOSS device. Subjects wi...
Eligibility Criteria
Inclusion
- 18 years or older
Exclusion
- No light perception
- Any systemic disease or disorder which would prohibit image aquisition
Key Trial Info
Start Date :
May 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 13 2022
Estimated Enrollment :
34 Patients enrolled
Trial Details
Trial ID
NCT05423041
Start Date
May 14 2022
End Date
September 13 2022
Last Update
May 4 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Vold Vision plc
Fayetteville, Arkansas, United States, 72704